# Intravenous (IV) Methylnaltrexone (MNTX) in the Prevention of Post-Operative Ileus

> **NCT01367548** · PHASE2 · COMPLETED · sponsor: **Bausch Health Americas, Inc.** · enrollment: 65 (actual)

## Conditions studied

- Postoperative Ileus

## Interventions

- **DRUG:** IV Methylnaltrexone (MNTX)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01367548
- **Lead sponsor:** Bausch Health Americas, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-07
- **Primary completion:** 2004-12
- **Final completion:** 2004-12
- **Target enrollment:** 65 (ACTUAL)
- **Last updated:** 2019-11-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01367548

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01367548, "Intravenous (IV) Methylnaltrexone (MNTX) in the Prevention of Post-Operative Ileus". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01367548. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*